Medicina

Medicine & Life Sciences

1. Mesenchymal Stem Cells 100%
2. Chile 68%
3. Exosomes 37%
4. Bipolar Disorder 36%
5. Extracellular Vesicles 33%
6. Stem Cells 28%
7. Pre-Eclampsia 27%
8. Pregnancy 25%
9. Cell- and Tissue-Based Therapy 24%
10. Post-Synaptic Density 22%
11. Serogroup 21%
12. Regulatory T-Lymphocytes 17%
13. Vaccines 17%
14. Mortality 16%
15. Mothers 16%
16. T-Lymphocytes 16%
17. Therapeutics 16%
18. Vaccination 16%
19. Meningococcal Infections 16%
20. MicroRNAs 16%
21. Biomarkers 16%
22. Th17 Cells 15%
23. Kidney 15%
24. Child 14%
25. Fluoxetine 14%
26. Fetal Growth Retardation 13%
27. Gestational Diabetes 13%
28. Proteins 13%
29. Phenotype 13%
30. Pneumococcal Infections 12%
31. Coronavirus 12%
32. Gingival Crevicular Fluid 12%
33. Regeneration 12%
34. Peroxisome Proliferator-Activated Receptors 12%
35. Health 12%
36. Immunosuppressive Agents 12%
37. Latin America 11%
38. Renal Dialysis 11%
39. Systemic Lupus Erythematosus 11%
40. Astrocytes 11%
41. Rheumatoid Arthritis 11%
42. Macrophages 11%
43. 10-valent pneumococcal conjugate vaccine 11%
44. First Pregnancy Trimester 11%
45. Pneumococcal Vaccines 11%
46. Mitochondria 10%
47. Pregnant Women 10%
48. Peritoneal Dialysis 10%
49. Population 10%
50. Placenta 10%
51. Neuropilin-1 9%
52. Seizures 9%
53. acylaminoacyl-peptidase 9%
54. SARS Virus 9%
55. Neurons 9%
56. Periodontitis 8%
57. Safety 8%
58. Immunization 8%
59. Neuronal Plasticity 8%
60. Conjugate Vaccines 8%
61. Communicable Diseases 8%
62. Cohort Studies 8%
63. Obesity 8%
64. Spironolactone 8%
65. Antidepressive Agents 8%
66. Umbilical Cord 8%
67. Prosencephalon 8%
68. Pneumonia 8%
69. Neisseria meningitidis 8%
70. Autoimmune Experimental Encephalomyelitis 8%
71. Synapses 7%
72. Transplantation Tolerance 7%
73. NFATC Transcription Factors 7%
74. Regenerative Endodontics 7%
75. Neurogenesis 7%
76. N-Methyl-D-Aspartate Receptors 7%
77. Depression 7%
78. Incidence 7%
79. Kainic Acid 7%
80. Immunization Programs 7%
81. Blood Vessels 7%
82. Chronic Renal Insufficiency 7%
83. Hypoxia 7%
84. Cost-Benefit Analysis 7%
85. Inflammation 6%
86. Meta-Analysis 6%
87. In Vitro Techniques 6%
88. Dental Pulp 6%
89. Case-Control Studies 6%
90. Gestational Age 6%
91. Fetus 6%
92. Genes 6%
93. Interleukin-33 6%
94. Infections 6%
95. Ischemia 6%
96. Reperfusion Injury 6%
97. Stem Cell Research 6%
98. Randomized Controlled Trials 6%
99. Adult Respiratory Distress Syndrome 6%
100. Autoimmune Diseases 6%